IGC Pharma, Inc. (IGC) — Institutional Holders, Q2 2026
36 institutional investment managers reported a IGC position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $1.4M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
IGC in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- AdvisorShares InvestmentsNew · +678,480 sh+$184.5K
- CITADEL ADVISORSNew · +437,317 sh+$119.0K
- VANGUARD CAPITAL MANAGEMENTAdded · +96,478 sh+$26.2K
- JANE STREET GROUPNew · +62,610 sh+$17.0K
- NORTHERNAdded · +56,867 sh+$15.5K
Biggest sellers
- RENAISSANCE TECHNOLOGIESTrimmed · -197,367 sh-$53.7K
- GEODE CAPITAL MANAGEMENTTrimmed · -163,990 sh-$44.6K
- SUSQUEHANNA INTERNATIONAL GROUP, LLPTrimmed · -93,713 sh-$25.5K
- Virtu FinancialSold out · -23,233 sh-$6.3K
- T3 CompaniesSold out · -20,000 sh-$5.4K
IGC 13F holders ranked 1–36 of 36
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | GEODE CAPITAL MANAGEMENT#1 · 879,394 sh | 879,394 | $239.2K | 0.00% | -15.7% |
| 2 | VANGUARD CAPITAL MANAGEMENT#2 · 814,914 sh | 814,914 | $221.7K | 0.00% | +13.4% |
| 3 | BlackRock#3 · 703,798 sh | 703,798 | $191.4K | 0.00% | 0.0% |
| 4 | AdvisorShares Investments#4 · 678,480 sh | 678,480 | $184.5K | 0.02% | New |
| 5 | CITADEL ADVISORS#5 · 437,317 sh | 437,317 | $119.0K | 0.00% | New |
| 6 | VANGUARD FIDUCIARY#6 · 419,413 sh | 419,413 | $114.1K | 0.00% | +0.8% |
| 7 | RENAISSANCE TECHNOLOGIES#7 · 286,608 sh | 286,608 | $78.0K | <0.01% | -40.8% |
| 8 | STATE STREET#8 · 200,799 sh | 200,799 | $54.6K | 0.00% | 0.0% |
| 9 | NORTHERN#9 · 170,274 sh | 170,274 | $46.3K | 0.00% | +50.1% |
| 10 | LAWOOD#10 · 75,000 sh | 75,000 | $20.4K | — | 0.0% |
| 11 | GOLDMAN SACHS GROUP#11 · 65,541 sh | 65,541 | $17.8K | 0.00% | 0.0% |
| 12 | JANE STREET GROUP#12 · 62,610 sh | 62,610 | $17.0K | 0.00% | New |
| 13 | DEARBORN PARTNERS#13 · 59,401 sh | 59,401 | $15.6K | <0.01% | 0.0% |
| 14 | TRUIST FINANCIAL#14 · 48,667 sh | 48,667 | $13.2K | 0.00% | +32.7% |
| 15 | CITIGROUP#15 · 46,043 sh | 46,043 | $12.5K | 0.00% | New |
| 16 | Fisher Asset Management#16 · 43,400 sh | 43,400 | $11.8K | 0.00% | 0.0% |
| 17 | XTX Topco Ltd#17 · 39,378 sh | 39,378 | $10.7K | <0.01% | -22.3% |
| 18 | MORGAN STANLEY#18 · 35,198 sh | 35,198 | $9.6K | 0.00% | +0.2% |
| 19 | COMMONWEALTH EQUITY SERVICES#19 · 33,348 sh | 33,348 | $9.1K | 0.00% | -1.5% |
| 20 | SUSQUEHANNA INTERNATIONAL GROUP, LLP#20 · 28,882 sh | 28,882 | $7.9K | 0.00% | -76.4% |
| 21 | Tower Research Capital (TRC)#21 · 27,607 sh | 27,607 | $7.5K | <0.01% | +31.2% |
| 22 | Vanguard Global Advisers#22 · 14,944 sh | 14,944 | $4.1K | 0.00% | 0.0% |
| 23 | Wealthcare Advisory Partners#23 · 10,000 sh | 10,000 | $2.7K | — | 0.0% |
| 24 | Burnham#24 · 5,000 sh | 5,000 | $1.4K | <0.01% | — |
| 25 | Geneos Wealth Management#25 · 3,000 sh | 3,000 | $810.00 | 0.00% | 0.0% |
| 26 | GROUP ONE TRADING, L.P.#26 · 2,600 sh | 2,600 | $707.00 | 0.00% | -30.9% |
| 27 | Rockefeller Capital Management L.P.#27 · 1,000 sh | 1,000 | $272.00 | 0.00% | New |
| 28 | BARCLAYS PLC#28 · 721 sh | 721 | $196.00 | 0.00% | New |
| 29 | Caitlin John#29 · 200 sh | 200 | $54.00 | 0.00% | 0.0% |
| 30 | Hurley Capital#30 · 100 sh | 100 | $27.00 | 0.00% | 0.0% |
| 31 | Farther Finance Advisors#31 · 101 sh | 101 | $27.00 | — | 0.0% |
| 32 | DHJJ Financial Advisors, Ltd.#32 · 80 sh | 80 | $22.00 | — | 0.0% |
| 33 | Napier Financial#33 · 58 sh | 58 | $16.00 | 0.00% | 0.0% |
| 34 | Johnson Financial Group#34 · 1 sh | 1 | $1.00 | 0.00% | 0.0% |
| 35 | Triumph Capital Management#35 · 2 sh | 2 | $1.00 | — | 0.0% |
| 36 | UBS Group AG#36 · 1 sh | 1 | $0.00 | 0.00% | -100.0% |
Funds that sold out of IGC in Q2 2026 (4)
Held IGC at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Virtu Financial23,233 sh | 23,233 | $6.0K |
| T3 Companies20,000 sh | 20,000 | $5.3K |
| HighTower Advisors10,000 sh | 10,000 | $2.6K |
| Schneider Downs Wealth Management Advisors10,000 sh | 10,000 | $2.6K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.